MedPath

Everbeat Ring ECG Clinical Concordance Study

Conditions
Cardiovascular Diseases
Registration Number
NCT05469542
Lead Sponsor
Grektek Inc.
Brief Summary

This study is a cross-sectional observational study conducted in patients referred for routine ECG, to compare output from the everbeat finger-worn ECG device to standard of care (SOC) 12-lead electrocardiography. No intervention is involved in this study. Patients visiting the study site during the study period will be assessed for eligibility on a convenience basis, and observational data will be recorded on those eligible.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
65
Inclusion Criteria
  • Males or females aged 18 to 90 years.
  • Under the care of a board-certified physician and referred for a routine electrocardiogram (ECG)
  • Resting heart rate between 50 to 120 beats per minute (BPM).
Exclusion Criteria
  • Inability to wear the everbeat ring.
  • Prior history of movement disorders including Parkinson's or benign tremors.
  • Prior history of allergic skin reactions to metal including stainless steel.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
R-wave Amplitude50 days

R Peak Amplitude intraclass correlation coefficient between test and reference devices in mm

ST-segment50 Days

Concordance in ST-segment deviation from the TP segment if present in mm

Blinded Cardiologist Review50 Days

Identify the first six consecutive distinct readable PQRST complexes without artifacts that match between the strips for evaluation. Each reviewer will assign a pass/fail to the strips by visually assessing all 6 PQRST complexes. A "pass" is given when the morphology of the PQRST complexes appears to overlay to the unaided eye. A measurement of the R amplitude from the isoelectric baseline to the nearest millimeter for the first two QRS complexes in both the reference strip and everbeat strip. The reviewers will be blinded to the identity of the reference strip and everbeat strip.

Secondary Outcome Measures
NameTimeMethod
User acceptance survey50 days

To assess the ease of use of the everbeat ring in a random selection of users.

Trial Locations

Locations (1)

BKLYNCardio

🇺🇸

Brooklyn, New York, United States

© Copyright 2025. All Rights Reserved by MedPath